Literature DB >> 7862955

von Hippel-Lindau disease: genetic, clinical, and imaging features.

P L Choyke1, G M Glenn, M M Walther, N J Patronas, W M Linehan, B Zbar.   

Abstract

von Hippel-Lindau (VHL) disease is an autosomal dominant disorder that causes retinal hemangioblastomas, hemangioblastomas of the central nervous system, endolymphatic sac tumors, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, and epididymal cystadenomas, among other less common manifestations. Although this entity has been recognized for almost 70 years, recent developments in the genetics and imaging of VHL disease have greatly improved understanding of the disease and its natural history. This review describes the major events that led to the discovery of the gene for VHL and will familiarize the reader with recent developments in the magnetic resonance Imaging, computed tomographic, and ultrasound findings of this entity. Despite advances in the genetic understanding of this disease, imaging techniques will continue to play a major role in the diagnosis, management, and treatment of VHL.

Entities:  

Mesh:

Year:  1995        PMID: 7862955     DOI: 10.1148/radiology.194.3.7862955

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  87 in total

1.  Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.

Authors:  A O Vortmeyer; I A Lubensky; F Fogt; W M Linehan; U Khettry; Z Zhuang
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.

Authors:  M T Sgambati; C Stolle; P L Choyke; M M Walther; B Zbar; W M Linehan; G M Glenn
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Molecular genetics of kidney cancer: implications for the physician.

Authors:  W M Linehan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-10

4.  Aggressive papillary tumor of the temporal bone: delayed extensive recurrence following radiation therapy.

Authors:  P C Patel; P K Pellitteri; C L Reams; J S Martin; M B Szymanski
Journal:  Skull Base Surg       Date:  1997

5.  Neurologic manifestations of von Hippel-Lindau disease.

Authors:  John A Butman; W Marston Linehan; Russell R Lonser
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

Review 6.  Neurology and the kidney.

Authors:  D J Burn; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

7.  Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort.

Authors:  Shannon Bradley; Nadine Dumas; Mark Ludman; Lori Wood
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 8.  Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.

Authors:  Jad Chahoud; Melissa McGettigan; Nainesh Parikh; Ronald S Boris; Othon Iliopoulos; W Kimryn Rathmell; Anthony B Daniels; Eric Jonasch; Philippe E Spiess
Journal:  World J Urol       Date:  2020-09-16       Impact factor: 4.226

9.  Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.

Authors:  Yves Pastore; Katerina Jedlickova; Yongli Guan; Enli Liu; James Fahner; Henrik Hasle; Jaroslav F Prchal; Josef T Prchal
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

10.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.